Thrombolysis with reteplase in acute pulmonary embolism

OBJECTIVE: Reteplase (recombinant plasminogen activator) is a mutant of alteplase. It has a longer half-life than its parent molecule and has shown better vessel patency rates in acute myocardial infarction. In this study, we analyzed the efficacy and safety of reteplase in acute pulmonary embolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishanth, K.R., Math, Ravi S., Shankar, Mythri, Ravindranath, K.S., Manjunath, C.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Originaln Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136336/
https://www.ncbi.nlm.nih.gov/pubmed/32248919
http://dx.doi.org/10.1016/j.ihj.2019.09.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136336/
https://www.ncbi.nlm.nih.gov/pubmed/32248919
http://dx.doi.org/10.1016/j.ihj.2019.09.011

Ejemplares similares